Hint mode is switched on Switch off
For swift navigation between sections

Indivior Pharmaceuticals
LEI 254900MKFFZZSS7N1I14

PDF download

Choose all Reset all
Download Cancel
Organization name
Indivior Pharmaceuticals, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
450 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Indivior Pharmaceuticals, Inc. is a global specialty pharmaceutical company focused on developing medicines for opioid addiction and other substance-use disorders

Awards

News

17/03/2026 New issue: Indivior Pharmaceuticals issued bonds with the coupon rate of 0.625% in the amount of USD 450 mln maturing in 2031
All organization news

Documentation

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    254900MKFFZZSS7N1I14
Registration is required to get access.